May 23, 2023 07:00 PM Eastern Daylight Time HAWTHORNE, N.Y.--( BUSINESS WIRE )--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2023. Quarter ended March 31, 2023* Highlights ─ compared to
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 24, 2023-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022 . Quarter ended December 31, 2022 * Highlights ─ compared to December 31,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 19, 2023-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022 , after the close of market on Tuesday, January 24, 2023 .
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2022 . Quarter ended September 30, 2022 * Highlights ─ compared to September